Grant: Catalyst Grant: Invention and High-Risk, High-Benefit Research
University of Toronto
$298,557.00
Development of the mammalian membrane two-hybrid technology.
FY 2008-09
Summary
Every cell in the human body contains proteins. They are the major part of the skin, muscles, organs, glands and also body fluids. While carrying out the essential functions of our body, proteins never act alone, they interact with many other proteins and these "contacts among proteins" are called protein-protein interactions. Among all proteins in human cells, a special role can be assigned to those associated with cellular membranes (so called membrane proteins) because their malfunctioning contributes to many human diseases including cancer, neurodegenerative diseases and developmental disorders. However, due to their complex biochemical features the study of membrane proteins has historically been extremely problematic making the study of their corresponding protein interactors even more challenging. The purpose of this proposal is to develop and implement a novel assay that can detect and monitor membrane protein-protein interactions in human cells. Such a method may have great applications for the field of molecular medicine since it may be used to identify novel proteins as components of many essential cellular processes. Furthermore, this assay may be of importance for the field of drug discovery since it may be used to identify drugs that disrupt a defined set of membrane protein interactions that occur only in a certain human disease.
Department
Program
Catalyst Grant: Invention and High-Risk, High-Benefit Research
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
182461
Name
Stagljar Igor
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Inventions, Technologies, or High Risk Grants
Projecttitle
Development of the mammalian membrane two-hybrid technology.
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$298,557
Cihrequipment2
$0
Programname2
Catalyst Grant: Invention and High-Risk, High-Benefit Research
Keyworddelim
Drug Targets; Membrane Proteins; Protein-Protein Interactions; Proteomics; Two-Hybrid System
Abstract
Every cell in the human body contains proteins. They are the major part of the skin, muscles, organs, glands and also body fluids. While carrying out the essential functions of our body, proteins never act alone, they interact with many other proteins and these "contacts among proteins" are called protein-protein interactions. Among all proteins in human cells, a special role can be assigned to those associated with cellular membranes (so called membrane proteins) because their malfunctioning contributes to many human diseases including cancer, neurodegenerative diseases and developmental disorders. However, due to their complex biochemical features the study of membrane proteins has historically been extremely problematic making the study of their corresponding protein interactors even more challenging. The purpose of this proposal is to develop and implement a novel assay that can detect and monitor membrane protein-protein interactions in human cells. Such a method may have great applications for the field of molecular medicine since it may be used to identify novel proteins as components of many essential cellular processes. Furthermore, this assay may be of importance for the field of drug discovery since it may be used to identify drugs that disrupt a defined set of membrane protein interactions that occur only in a certain human disease.
Competitiondate
200903
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Stagljar, Igor
Approvedterm
3 ans 0 mois
Cihrcontribution2
Institute of Genetics~ $118,557~ $0~Pan - Institute init. (MISI)~ $180,000~ $0~